Valneva - Assemblée Générale des actionnaires du 22 décembre 2020
La présente assemblée générale a été convoquée suite à l’objectif de la société de se coter aux Etats-Unis.
La société communique donc : « Nous vous indiquons que l’ensemble des résolutions soumises à votre approbation vise à permettre à notre Société de réaliser, le cas échéant, son introduction en bourse sur le Nasdaq, à l’instar de nombreuses autres sociétés évoluant dans notre secteur d’activité. Nous attirons votre attention que si ce projet venait à se concrétiser, nous utiliserions soit la 3ème résolution, soit la 6ème résolution présentées à votre approbation. Nous vous précisons que la mise en œuvre de l’une ou l’autre de ces deux résolutions est exclusive du droit préférentiel de souscription des actionnaires. »
Proxinvest regrette le montant et les décotes proposées au sein de ces résolutions.
Valneva, together with its subsidiaries, is focused on vaccine development and antibody discovery. Co. generates revenue from both its marketed product, a vaccine for the prevention of Japanese encephalitis (IXIARO®/JESPECT®), commercial partnerships around a portfolio of product candidates and licensed technology platforms (EB66® cell line, VIVA,Screen antibody discovery technology, and the IC31® adjuvant) developed by Co. Related business activities include product research and development, regulatory and clinical activities, manufacturing of commercial product and advanced clinical product candidates, as well as administrative, corporate development, and marketing and sales activities.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
- Proxy reports
- Definition and monitoring of client customized voting guidelines
- Corporate Governance Data and Rating
- Thematic research
- Engagement support
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.